Evaluation of professional practice in the management of COPD at Montpellier University Hospital

被引:3
作者
Gheffari, I. [1 ]
Bourdin, A. [1 ]
Chanez, P. [1 ]
Godard, P. [1 ]
机构
[1] CHU Arnaud de Villeneuve, Serv Malad Resp, F-34295 Montpellier 5, France
关键词
Chronic obstructive pulmonary disease; Evaluation of professional practices; Smoking; Lung functioning testing; Expertise; ACUTE EXACERBATIONS; MORTALITY;
D O I
10.1016/j.rmr.2010.03.017
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction. - Chronic obstructive pulmonary disease (COPD), because of its severity and prevalence, is an important target for the evaluation of professional practices. We present the results of an evaluation at Montpellier University Hospital in 2006 (number of admissions 4800/yr). Results. - One hundred and twenty-one observations were retrieved, 8% of the total where COPD was recorded as the principal diagnosis (Median age: 66 years; male: 67%). Eighty-eight per cent of the patients had undergone thoracic radiography and 50.8% had had lung function testing. Body mass index was recorded for 89.9% of the patients and the annual number of exacerbations in 14.9%. Information on smoking cessation was given to only 41.9% of the patients, pulmonary rehabilitation was considered in 14.5% and bronchodilators and/or inhaled corticoids were prescribed for 47.8%. Patients admitted under the care of a respiratory team were significantly more likely to have received information on the means of smoking cessation: 75% vs. 35% (p: 0.0004), lung function testing: 73% vs. 38% (p: 0.0005) and been offered pulmonary rehabilitaion: 35% vs. 5% (p < 0.0001). Conclusion. - There is considerable room for improvement in the care of COPD within the hospital in order for it to conform to national and international guidelines. Specialist respiratory care is more adherent with guidelines than non-specialist care. (C) 2010 SPLF. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 19 条
[1]  
BENARD E, 2005, LETT PNEUMOLOGUE, P159
[2]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[3]   Epidemiology and costs of chronic obstructive pulmonary disease [J].
Chapman, KR ;
Mannino, DM ;
Soriano, B ;
Vermeire, PA ;
Buist, AS ;
Thun, MJ ;
Connell, C ;
Jemal, A ;
Lee, TA ;
Miravitlles, M ;
Aldington, S ;
Beasley, R .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (01) :188-207
[4]  
FISTCH K, 2005, SWISS MED WEEKLY, V135, P116
[5]   Economic burden of COPD: the SCOPE study [J].
Fournier, M ;
Tonnel, AB ;
Housset, B ;
Huchon, G ;
Godard, P ;
Vervloet, D ;
Huas, D ;
Durand-Zaleski, I ;
Chanal, I ;
Pribil, C .
REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) :247-255
[6]   Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study [J].
Jenkins, Christine R. ;
Jones, Paul W. ;
Calverley, Peter M. A. ;
Celli, Bartolome ;
Anderson, Julie A. ;
Ferguson, Gary T. ;
Yates, Julie C. ;
Willits, Lisa R. ;
Vestbo, Joergen .
RESPIRATORY RESEARCH, 2009, 10
[7]  
MCINTYRE NR, 2001, RESP CARE, V46, P1294
[8]   Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD [J].
Miravitlles, M ;
Murio, C ;
Guerrero, T ;
Gisbert, R .
CHEST, 2002, 121 (05) :1449-1455
[9]  
MOLINIE F, 2003, BRONCHOPNEUMOPATHIES, P15
[10]   In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease [J].
Patil, SP ;
Krishnan, JA ;
Lechtzin, N ;
Diette, GB .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (10) :1180-1186